These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23573618)

  • 1. [Therapy decision - patient participation?]].
    Hilfrich J; Jänicke F
    Onkologie; 2002 Dec; 25 Suppl 5():25-7. PubMed ID: 23573618
    [No Abstract]   [Full Text] [Related]  

  • 2. [DCIS and HER2/neu].
    Tulusan AH
    Onkologie; 2002 Dec; 25 Suppl 5():11-2; discussion 13. PubMed ID: 23573612
    [No Abstract]   [Full Text] [Related]  

  • 3. [Herceptin monotherapy in HER2(+) recurrent breast carcinoma].
    Eidtmann H
    Onkologie; 2002 Dec; 25 Suppl 5():14-5. PubMed ID: 23573613
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeting adjuvant chemotherapy: a good idea that needs to be proven!
    Hayes DF
    J Clin Oncol; 2012 Apr; 30(12):1264-7. PubMed ID: 22355050
    [No Abstract]   [Full Text] [Related]  

  • 5. [Adjuvant therapy with trastuzumab (Herceptin) in primary breast cancer].
    Huober J; Jackisch C; Untch M; Möbus V; Wallwiener D; Kaufmann M; Minkwitz G
    Zentralbl Gynakol; 2006 Feb; 128(1):30-7. PubMed ID: 16450285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuation of trastuzumab beyond disease progression.
    Montemurro F; Faggiuolo R; Redana S; Donadio M; Minischetti M; Durando A; Vietti-Ramus G; Buosi R; Aglietta M
    J Clin Oncol; 2005 Apr; 23(12):2866-8; discussion 2868-9. PubMed ID: 15838006
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy concept: herceptin in combination with arimidex].
    von Minckwitz G
    Onkologie; 2002 Dec; 25 Suppl 5():22 ; discussion 22-4. PubMed ID: 23573617
    [No Abstract]   [Full Text] [Related]  

  • 8. Herceptin (trastuzumab): adjuvant and neoadjuvant trials.
    Yaal-Hahoshen N; Safra T
    Isr Med Assoc J; 2006 Jun; 8(6):416-21. PubMed ID: 16833172
    [No Abstract]   [Full Text] [Related]  

  • 9. Does trastuzumab increase the risk of isolated CNS metastases in patients with breast cancer?
    Abrey LE
    Nat Clin Pract Neurol; 2006 Jun; 2(6):302-3. PubMed ID: 16932571
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy concept: herceptin with anthracyclines].
    Untch M
    Onkologie; 2002 Dec; 25 Suppl 5():19-21; discussion 21. PubMed ID: 23573616
    [No Abstract]   [Full Text] [Related]  

  • 11. [Combination therapy herceptin+xeloda].
    Schaller G
    Onkologie; 2002 Dec; 25 Suppl 5():17-8; discussion 19. PubMed ID: 23573615
    [No Abstract]   [Full Text] [Related]  

  • 12. Neoadjuvant trastuzumab for breast cancer. Better to stick with proven treatments.
    Prescrire Int; 2013 Feb; 22(135):39. PubMed ID: 23444499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [About standard: from rule to patient. Breast cancer as an example].
    Vennin P; Taïeb S; Carpentier P
    Bull Cancer; 2001 Feb; 88(2):221-2. PubMed ID: 11257598
    [No Abstract]   [Full Text] [Related]  

  • 14. Patient demand and politics push Herceptin forward.
    Kondro W; Sibbald B
    CMAJ; 2005 Aug; 173(4):347-8. PubMed ID: 16103498
    [No Abstract]   [Full Text] [Related]  

  • 15. [Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study].
    Mallmann P
    Internist (Berl); 2006 Nov; 47(11):1183-5. PubMed ID: 17048017
    [No Abstract]   [Full Text] [Related]  

  • 16. Tako-Tsubo syndrome after trastuzumab - an unusual complication of chemotherapy for breast cancer.
    Khanji M; Nolan S; Gwynne S; Pudney D; Ionescu A
    Clin Oncol (R Coll Radiol); 2013 May; 25(5):329. PubMed ID: 23434354
    [No Abstract]   [Full Text] [Related]  

  • 17. T-DM1 aids patients with advanced breast cancer.
    Cancer Discov; 2013 Dec; 3(12):OF5. PubMed ID: 24327714
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy: what progress in the last 5 years?
    Hamilton A; Hortobagyi G
    J Clin Oncol; 2005 Mar; 23(8):1760-75. PubMed ID: 15755984
    [No Abstract]   [Full Text] [Related]  

  • 19. Trastuzumab emtansine for advanced HER2-positive breast cancer and beyond: genome landscape-based targets.
    Cho WC; Roukos DH
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):5-8. PubMed ID: 23259420
    [No Abstract]   [Full Text] [Related]  

  • 20. [Healing in sight?].
    Jackisch C
    Krankenpfl J; 2005; 43(4-6):137. PubMed ID: 16171079
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.